Indaptus Therapeutics Files 8-K on Financials

Ticker: INDP · Form: 8-K · Filed: Mar 13, 2025 · CIK: 1857044

Indaptus Therapeutics, INC. 8-K Filing Summary
FieldDetail
CompanyIndaptus Therapeutics, INC. (INDP)
Form Type8-K
Filed DateMar 13, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-condition, operations, disclosure

TL;DR

Indaptus Therapeutics (INDP) filed an 8-K detailing financial condition and operations as of March 13, 2025.

AI Summary

Indaptus Therapeutics, Inc. filed an 8-K on March 13, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 3 Columbus Circle, New York, NY. Indaptus Therapeutics, Inc. was formerly known as Intec Parent Inc. until April 14, 2021.

Why It Matters

This 8-K filing provides an update on Indaptus Therapeutics' financial condition and operations, which is crucial information for investors to assess the company's performance and future prospects.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate negative news or significant changes.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on Indaptus Therapeutics, Inc.'s results of operations and financial condition, and to include financial statements and exhibits.

When was this 8-K report filed?

This 8-K report was filed on March 13, 2025.

Where are Indaptus Therapeutics, Inc.'s principal executive offices located?

Indaptus Therapeutics, Inc.'s principal executive offices are located at 3 Columbus Circle, 15th Floor, New York, New York, 10019.

What was Indaptus Therapeutics, Inc. formerly known as?

Indaptus Therapeutics, Inc. was formerly known as Intec Parent Inc.

On what date did the company change its name from Intec Parent Inc.?

The company changed its name from Intec Parent Inc. on April 14, 2021.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 13, 2025 regarding Indaptus Therapeutics, Inc. (INDP).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing